1. Differential Effects of AZD-1208 and SMI-4a, Two Pim-1 Kinase Inhibitors on Primary HAM/TSP and ATL Cells
- Author
-
Jean-Baptiste, D, Belrose, G, Meniane, JC, Lézin, A, Jeannin, S, Mesnard, JM, Olindo, S, Peloponese, Jean-Marie, Césaire, R, Institut de Recherche en Infectiologie de Montpellier (IRIM), and Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
immune system diseases ,viruses ,hemic and lymphatic diseases ,Adult T-cell leukemia ,virus diseases ,PIM-1 ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,[SDV.BC]Life Sciences [q-bio]/Cellular Biology ,HAM/TSP - Abstract
International audience; Adult T-cell Leukemia-lymphoma (ATL), an aggressive neoplasm etiologically associated with HTLV-1, is a chemoresistant malignancy. Proviral integration site for Moloney murine leukemia virus-1 (Pim-1) is a critical enzyme that is involved in cell growth, differentiation, survival, apoptosis, senescence and drug resistance. Interaction of Pim-1 with different proteins and association with various signaling pathways make it one of the important antitumor targets. Aberrant elevation of Pim-1 kinase is associated with numerous types of cancer. In this study, we showed that Pim-1 kinase is highly expressed in ATL, as well as in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Numerous Pim-1 inhibitors are under preclinical studies or clinical trials, such as AZD1208. An increasing number of new Pim-1 inhibitors are still developing and undergoing preclinical investigations. Next, we compared the effect of two PIM-1 inhibitors, AZD-1208 and SMI-4a on HTLV-1-derived cells lines and ex vivo cultured primary HAM/TSP and ATL leukemic cells. Our results show a differential effects between AZD on survival and proliferation of vs. HTLV-1 derived cells lines. Our results underscore the strong therapeutic potential of Pim kinase inhibition for the treatment of HTLV related pathogenesis such as HAM/TSP and ATL 3
- Published
- 2017